Abvc Biopharma (ABVC) Interest & Investment Income (2015 - 2026)
Abvc Biopharma (ABVC) reported Interest & Investment Income of $683.00 for Q2 2026, down 96.4% from $19,139 a year earlier and down 81.9% from the prior quarter.
Powered by 
Analysis
Abvc Biopharma (ABVC) Interest & Investment Income (2015 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Abvc Biopharma's Interest & Investment Income came in at $133,341, up 41.3% year-over-year; for FY2025, it was $167,103, up 91.3% from FY2024.
- Interest & Investment Income has a five-year compound annual growth rate of 18.7% (FY2020 to FY2025).
- By year, Interest & Investment Income came in at $87,358 in FY2024 (-52.9%), $185,481 in FY2023 (-1.2%), $187,817 in FY2022 (+334.8%) and $43,196 in FY2021 (-39.2%).
- The Q2 2026 figure ranks as the lowest quarterly Interest & Investment Income since Q4 2021.
- Year over year, Interest & Investment Income gained in four of the last eight quarters, with growth averaging 87.3%.
- The high point for year-over-year Interest & Investment Income in five years was Q4 2025 (growth of 585.4%); the low point was Q2 2026 (a decline of 96.4%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $3,765 (Q1 2026), $81,606 (Q4 2025) and $47,287 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | - |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 219.00 Mn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | - |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | - |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 80.00 Mn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | - |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | - |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | - |
| 10 | Abvc Biopharma | 26.03 Mn | 28.01 Mn | - | 683.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 683.00 |
| Mar 31, 2026 | 3,765.00 |
| Dec 31, 2025 | 81,606.00 |
| Sep 30, 2025 | 47,287.00 |
| Jun 30, 2025 | 19,139.00 |
| Mar 31, 2025 | 19,071.00 |
| Dec 31, 2024 | 11,907.00 |
| Sep 30, 2024 | 44,261.00 |
| Jun 30, 2024 | 27,141.00 |
| Mar 31, 2024 | 4,049.00 |
| Dec 31, 2023 | 37,483.00 |
| Sep 30, 2023 | 40,246.00 |
| Jun 30, 2023 | 55,041.00 |
| Mar 31, 2023 | 52,711.00 |
| Dec 31, 2022 | 60,463.00 |
| Sep 30, 2022 | 48,164.00 |
| Jun 30, 2022 | 39,015.00 |
| Mar 31, 2022 | 40,175.00 |
| Dec 31, 2021 | -29,388.00 |
| Sep 30, 2021 | 9,333.00 |
API Access
Abvc Biopharma Interest & Investment Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=interest-and-investment-income&ticker=ABVC&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "interest-and-investment-income", "ticker": "ABVC", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=interest-and-investment-income&ticker=ABVC&period=max&api_key=YOUR_API_KEY");
const data = await res.json();